Neocuproine potentiates the activity of the nitrergic neurotransmitter but inhibits that of S-nitrosothiols.
In the present study, we investigated the cellular components that are involved in the release of nitric oxide (NO) from S-nitrosothiols and whether these components also modulate the activity of the nitrergic neurotransmitter in the rat gastric fundus. Electrical stimulation of nitrergic nerves induced frequency-dependent transient relaxations which were mimicked by exogenous NO. The S-nitrosothiols S-nitrosocysteine, S-nitrosoglutathione and S-nitroso-N-acetylpenicillamine induced concentration-dependent relaxations which were generally more sustained as compared to those to nitrergic nerve stimulation or NO. The relaxations to nitrergic nerve stimulation and those to NO were significantly enhanced by the copper(I) chelator neocuproine but not affected by the copper(II) chelator cuprizone. The relaxations to the S-nitrosothiols were significantly inhibited by neocuproine but not by cuprizone. The antioxidant ascorbate did not affect the tension of the muscle strip. However, in the presence of an S-nitrosothiol, ascorbate induced an immediate, sharp and transient relaxation that was significantly inhibited by a low concentration of neocuproine but not by cuprizone. Ascorbate did not induce a relaxation during short-train or prolonged nerve stimulation of the muscle strip. These results suggest that ascorbate interacts with copper to modulate the biological activity of S-nitrosothiols but not that of the nitrergic neurotransmitter. The differential effect of neocuproine indicates that S-nitrosothiols do not mediate the nitrergic neurotransmission of the rat gastric fundus. As neocuproine is to date the only compound that exerts an opposite effect on the biological activity of the nitrergic neurotransmitter and on that of S-nitrosothiols, it may be useful to elucidate the nature of the nitrergic neurotransmitter in the peripheral nervous system.
De Man
J G
JG
Division of Gastroenterology, Faculty of Medicine, University of Antwerp (UIA), Belgium.
Moreels
T G
TG
De Winter
B Y
BY
Herman
A G
AG
Pelckmans
P A
PA
D000255:Adenosine Triphosphate / Q000494:pharmacology; D000818:Animals; D001205:Ascorbic Acid / Q000494:pharmacology; D002614:Chelating Agents / Q000494:pharmacology*; D003471:Cuprizone / Q000494:pharmacology; D004558:Electric Stimulation; D005748:Gastric Fundus / Q000187:drug effects / Q000294:innervation; D007537:Isometric Contraction / Q000187:drug effects; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009130:Muscle, Smooth / Q000187:drug effects / Q000294:innervation; D018377:Neurotransmitter Agents / Q000502:physiology*; D009566:Nitrates / Q000494:pharmacology; D009569:Nitric Oxide / Q000502:physiology*; D010618:Phenanthrolines / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D013438:Sulfhydryl Compounds / Q000037:antagonists & inhibitors*
D002614:Chelating Agents; D008996:Monoamine Oxidase Inhibitors; D018377:Neurotransmitter Agents; D009566:Nitrates; D010618:Phenanthrolines; D013438:Sulfhydryl Compounds; D009569:Nitric Oxide; D003471:Cuprizone; C002701:neocuproine; D000255:Adenosine Triphosphate; C031618:sodium nitrate; D001205:Ascorbic Acid